BIO vs RCMT · rev $2.58B vs P/E 14, $181.8M cap
BIO (BIO) versus RCM Technologies Inc (RCMT) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
RCM Technologies Inc (RCMT) is a conglomerates company listed on US.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
RCMT does not have a complete income-statement cache yet.
BIO currently screens at market cap $0. RCMT currently screens at market cap $181.8M and trailing P/E 14.1.
Not investment advice. Open the BIO and RCMT stock pages for the full models.
Not investment advice.